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Background: A retrospective clinical-histopathological study was made of the evolution of oral leukoplakia over 
time, staging the disease according to the classification of van der Waal. 
Material and Methods: A study was made of 412 patients with oral leukoplakia, analyzing the corresponding cli-
nical factors and histopathological findings; assessing associations between the different clinical presentations and 
epithelial dysplasia; and evaluating the factors influencing malignant transformation of the lesions. 
Results: Clinically, homogeneous presentations were seen to predominate (n = 336, 81.6%), while histologically 
most of the lesions exhibited no dysplastic changes (n = 271; 65.7%). Stage 1 of the van der Waal classification was 
the most common presentation (n = 214; 51.9%). The lesion malignization rate was 8.3%, and the factors associated 
to a significantly increased malignization risk were non-homogeneous OL lesions (p=0.00), lesion location in the 
tongue (p=0.00), and the presence of epithelial dysplasia (p=0.00). 
Conclusions: In our series of patients with oral leukoplakia, malignization was associated to the less common clini-
cal presentations of the disease, i.e., non-homogeneous lesions, and the latter tended to exhibit high grade epithelial 
dysplasia.




Oral leukoplakia (OL) is the most common  potentially 
malignant lesion of the oral mucosa (1), with an estima-
ted prevalence of 2% in the general population. The an-
nual incidence of transformation into oral squamous cell 
carcinoma (OSCC) is estimated to be 1% for all types of 
OL (2). 
Oral leukoplakia is defined as “a whitish plaque of doub-
tful risk after discarding other known disorders that do 
not pose an increased risk of cancer”. In the year 2015, 
van der Waal (3) defined OL as a predominantly white 
plaque that cannot be clinically or pathologically attribu-
ted to any other disorder. Oral leukoplakia is associated 
to a high risk of cancer development either in an area 
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close to the leukoplakia lesion or in any other part of the 
oral cavity or head and neck region.
The prevalence of OL is reportedly higher in males be-
tween the fourth and seventh decade of life (4). In etio-
logical terms, leukoplakia is divided into two groups: (a) 
idiopathic leukoplakia, in which no causal factors have 
been established; and (b) smoking-related leukoplakia 
(5). Indeed, smoking is the main established causal fac-
tor underlying these potentially malignant lesions (5,6). 
A synergic effect has also been reported between alcohol 
and smoking in relation to the development of leukopla-
kia and oral cancer (1).
Other described etiological factors are Sanguinaria ca-
nadensis contained in toothpastes and oral rinses, in-
fectious agents such as Candida, human papillomavirus 
(HPV) and bacteria, nutritional and socioeconomic fac-
tors, and certain systemic disorders (6).
From the clinical perspective, two types of leukoplakia 
have been established: homogeneous and non-homoge-
neous (7). A biopsy with histopathological evaluation is 
required in order to establish the definitive diagnosis (8). 
Recent guidelines recommend differentiation between 
low and high risk lesions.
Although many treatment strategies have been propo-
sed, there is no consensus regarding the best manage-
ment option for OL (7). No concrete treatment has been 
shown to effectively prevent recurrences or the possi-
ble future development of OSCC (9). Surgical removal 
(conventional or laser-based) of the lesions is advised, 
with subsequent follow-up.
There is a some agreement that certain factors are in-
dicative of possible malignant transformation of OL. 
Specifically, malignant transformation is considered to 
be more likely in women, in patients with long-evol-
ving lesions, OL located on the tongue and/or floor of 
the mouth, lesions measuring over 200 mm2 in size, 
non-homogeneous lesions, and particularly OL exhibi-
ting dysplasia in the biopsy study (10).
None of the aforementioned factors have been shown to 
be individually predictive of possible progression towards 
cancer in patients with OL. It therefore would be of inte-
rest to conduct studies involving large series of patients 
with OL in order to assess possible relationships among 
the different risk factors. In this regard, the present study 
was designed with the following objectives: (a) to assess 
possible associations between the clinical forms and the 
presence of epithelial dysplasia; and (b) to evaluate the 
evolution of the lesions after a minimum follow-up period 
of 5 years, and explore possible associations between the 
clinical forms and the presence of epithelial dysplasia and 
progression towards malignancy.
Material and Methods
A retrospective clinical-histopathological study was 
made of 412 patients with OL diagnosed and treated in 
the Department of Stomatology and Maxillofacial Sur-
gery (Valencia University General Hospital, Valencia, 
Spain) during the period 1994-2017. All patients met 
the clinical and histological conditions for establishing 
a firm diagnosis of leukoplakia, based on the diagnos-
tic criteria of Warnakulasuriya et al. (2007) (11). In this 
regard, we included homogeneous leukoplakia, and 
among the non-homogeneous lesions we excluded pro-
liferative verrucous leukoplakia. We also excluded cases 
in which the histopathological findings indicated carci-
noma in situ and microinvasive carcinoma.
All patients underwent a first visit with the recording of 
a detailed case history, clinical exploration and photo-
graphic registry of all the lesions. A biopsy for histologi-
cal study was obtained during a second visit.
The study was approved by the Ethics Committee of the 
University of Valencia (Valencia, Spain) (registry no. 
H1456655015143).
The histological results of the biopsy were recorded (no 
dysplasia, mild dysplasia, moderate or severe dysplasia), 
together with the type of treatment provided (surgery or 
CO2 laser vaporization at a power setting of 15 W; in 
the case of the latter treatment modality, the lesion was 
always biopsied first in order to conduct the histological 
study).
The outcome of the lesions after 5 years of follow-up 
was recorded and classified as cure, recurrence, no 
changes, and progression towards cancer. Of the 412 
patients, 73 (17.7%) were subjected to 10 years of fo-
llow-up, while 151 patients (36.7%) were followed-up 
on during 5 years.
-Statistical analysis
A descriptive statistical analysis was made, with calcu-
lation of the mean, standard deviation (SD) and mini-
mum and maximum values in the case of quantitative 
variables. Nonparametric tests (Kaplan-Meier survival 
analysis) were used to evaluate the number of patients 
progressing towards malignancy in each of the groups. 
The chi-squared test was used to assess the existence of 
significant differences between them. Statistical signifi-
cance was considered for p < 0.05.
Results
-Demographic data and habits
The mean age of our 412 patients with OL was 56.93 ± 
13.76 years (range 19-89), and females (n = 281) predo-
minated over males (n = 131). Most of the patients were 
non-smokers (n = 219; 53.2%) and did not consume al-
cohol (n = 350; 85%).
-Clinical and histopathological findings
Most of the patients (n = 327; 79.4%) were referred to 
our Department by a healthcare professional. The le-
sions were generally asymptomatic (n = 364; 88.3%).
Homogeneous leukoplakia predominated (n = 336; 
81.6%), while among the non-homogeneous forms of 
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the disease (n = 76; 18.4%) the verrucous subtype was 
the most common presentation (n = 39; 9.5%).
The mean lesion diameter was 18.64 ± 14.92 mm (range 
1-90). In turn, the most frequently affected location was 
the gums (n = 168; 40.8%), followed by the tongue (n 
= 138; 33.5%) and the cheek mucosa (n = 130; 31.6%).
Histologically, most of the lesions (n = 271; 65.7%) 
showed no dysplasia, while dysplasia was observed in 
141 lesions (34.3%) – with mild dysplasia being the 
most common presentation in the latter group (n = 98; 
23.8%).
The lesions were graded based on the classification (LP) 
of van der Waal (2013) (3). Over half of the lesions (n = 
214; 51.9%) corresponded to grade L1P0. With regard 
to staging of the lesions, stage 1 was the most common 
presentation (n = 214; 51.9%).
A total of 339 patients (82.3%) were subjected to con-
ventional surgical treatment, while 73 (17.7%) un-
derwent CO2 laser vaporization of the lesions.
Most of the lesions either remained without changes 
over follow-up (n = 164; 39.8%) or were cured (n = 160; 
38.8%). Thirty-four patients (8.3%) showed progression 













Referral by healthcare professional 327 (79.4)









 Spotted 14 (3.4)
 Nodular 22 (5.3)
 Verrucose 39 (9.5)







Floor of mouth 46 (11.2)
Cheek mucosa 130 (31.6)
Bilateral involvement 59 (14.3)
Histology
No dysplasia 271 (65.7)
Dysplasia 141 (34.3)
   Mild 98 (23.8)
   Moderate 34 (8.3)














Stage 1 214 (51.9)
Stage 2 116 (28.2)
Stage 3 57 (13.8)






Progressions towards cancer 34 (8.3)
Progression towards dysplasia 2 (0.5)




Without changes 164 (39.8)
Table 1 cont.: Characteristics of the patients included in the study.
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Table 2 shows the results referred to the association 
between the clinical types of OL and patient age and 
gender, lesion size and location, and the histological fin-
dings.
The patients with clinically non-homogeneous lesions 
were significantly older (mean 60.18 years; p = 0.02). 
The non-homogeneous lesions were also significantly 
larger (mean 22.63 mm; p=0.01).
On the other hand, the lesions located in the floor of the 
mouth and tongue were the only lesions to exhibit sta-
tistically significant differences on analyzing the asso-
ciation between lesion location and clinical presentation 
– most of the lesions being non-homogeneous (p = 0.03) 
and homogeneous (p<0.01), respectively.
Most of the homogeneous OL lesions exhibited no epi-
thelial dysplasia (92.5%). Severe dysplasia was signifi-
cantly more frequent in the patients with non-homoge-
neous lesions (5.3%; p = 0.00).
With regard to smoking habit, non-homogeneous lesions 
were significantly more common among non-smokers 
(65.8%; p=0.02). However, no statistically significant 
differences were observed on evaluating the association 
between clinical presentation and alcohol (p = 0.58).
Table 3 shows the risk factors corresponding to malig-
nant transformation of the lesions. Only four factors 
were found to be significantly associated to increased 
transformation risk: non-smokers (p=0.001), non-homo-
geneous lesions (p=0.00), lesion location in the tongue 
(p ≤ 0.01) and the presence of epithelial dysplasia (p ≤ 
0.01). 
VARIABLES CLINICAL PRESENTATION P-value
Homogeneous Non-homogeneous
Age (years) 56.19 60.18 0.002
Gender
Males 45.8% 35.5% 0.10
Females 54.2% 64.5%
Smoking habit
Smokers 49.7% 34.2% 0.02
Non-smokers 50.3% 65.8%
Alcohol consumption
Yes 14.6% 17.1% 0.58
No 85.4% 82.9%
Size (mm) 17.72 22.63 0.01
Location
Tongue 69.9% 51.3% 0.00
Gums 57.4% 67.1% 0.12
Lips 94.6% 98.7% 0.13
Palate 91.7% 89.5% 0.54
Floor of the mouth 87.2% 96.1% 0.03
Cheek mucosa 67.9% 71.1% 0.59
Bilateral involvement 85.7% 85.5% 0.97
Histology
No dysplasia 92.5%7 6.3%
0.00Dysplasia 7.5% 23.7%
   Mild 23.8% 23.7%
0.00   Moderate 6.0% 18.4%
   Severe 1.5% 5.3%
Table 2: Association between the different study variables and the clinical presentation of the lesions.





Age (years) ≥ 60
Student t = 1.38
0.17
Gender c2 = 0.02
Males 42.9% 0.89
Females 57.1%
Smoking habit c2 = 6.86
Smokers 25.7% 0.01
Non-smokers 74.3%
Size (mm) ≥ 22.4 Student t = 1.56 0.12




Tongue 77.1% c2 = 32.71 0.00
Gums 12.3% c2 = 11.12 0.01
Lips 8.7% c2 = 0.27 0.6
Palate 9% c2 = 1.66 0.19
Floor of the mouth 8.7% c2 = 0.26 0.6
Cheek mucosa 9.6% c2 = 1.34 0.25
Bilateral involvement 9.1% c2 = 1.03 0.31




   Mild 7.1%
   Moderate 23.5%
   Severe 44.4%
Table 3: Malignant transformation risk factors.
Discussion
The present study included 412 patients with the clinical 
and histopathological features defining oral leukoplakia. 
The mean patient age at lesion onset was 56.93 years, 
which is consistent with the observations of authors 
such as Silverman and Gorsky (12), and Schepman et 
al. (13). Likewise, and in concordance with the data pu-
blished by Napier et al. (14), women were found to be 
more affected than men. However, most studies in the 
literature describe a greater prevalence among males. 
The female predominance seen in our series thus could 
constitute a limitation on establishing comparisons with 
other studies. 
Smoking is known to be the main etiological factor in 
OL (10). However, in our series most of the patients 
(53.2%) were non-smokers. This observation could be 
related to the fact that most of our patients were women 
– and smoking is largely associated to the male gender. 
Although regular alcohol intake is also considered to be 
a risk factor (15), most of our patients were not regu-
lar consumers of alcohol. On the other hand, smoking 
is considered to possibly influence the clinical presen-
tation and location of the lesions (8). In this regard, and 
in agreement with the observations of Vladimirov et al. 
(16), we recorded a significant association between non-
smoker status and the presence of clinically non-homo-
geneous lesions.
Most patients with leukoplakia are unaware of the pre-
sence of these lesions in their oral cavity. On examining 
the main reasons for visiting the specialist, we found 
most of the patients (79.4%) to have been referred by 
a healthcare professional, thus reflecting the importan-
ce of the physician or dentist in establishing the diag-
nosis of the disease. The great majority of our patients 
(88.3%) reported no symptoms. This evidences that OL 
is usually asymptomatic, and that the development of 
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pain or discomfort may be associated to the presence of 
malignant transformation (17).
Clinically, leukoplakia usually manifests as a homoge-
neous lesion. In a study on the prevalence of OL in the 
United States, Scheifele et al. (18) found homogeneous 
lesions to clearly predominate (86.8%) over non-homo-
geneous lesions (13.2%). Our own findings are consis-
tent with the data reported in the literature, since 81.6% 
of the patients presented clinically homogeneous lesions 
versus 18.4% with non-homogeneous lesions.
Histologically, most of the OL lesions in our series of 
412 patients showed no epithelial dysplasia (65.7%). 
Among the lesions exhibiting dysplasia, we found mild 
dysplasia to predominate (23.8%) – this being consistent 
with the observations of different authors Vázquez-Al-
varez et al. (19).
With regard to the association between the clinical 
manifestations of the lesions and the histopathological 
findings, the literature describes that homogeneous le-
sions generally do not exhibit epithelial dysplasia, while 
non-homogeneous lesions are associated to high grades 
of dysplasia (14). In our series, practically none of the 
homogeneous lesions presented epithelial dysplasia 
(92.5%); furthermore, the percentage of lesions with 
moderate dysplasia (18.4%) and severe dysplasia (5.3%) 
was significantly greater in the non-homogeneous OL 
lesions.
Van der Waal (2) proposed a classification and staging 
system considering lesion size and histopathological fea-
tures. In our series, most of the patients presented grade 
L1P0 lesions, corresponding to stage 1 disease. This is 
consistent with the results of the study published by Star-
zyńska et al. (20), though Brouns et al. (10) found stage 
3 to be the most frequent presentation in their patients. 
There is currently no consensus regarding the best treat-
ment strategy for patients with OL (7). The main objecti-
ve is to avoid malignant transformation (21), though ma-
nagement is difficult, since most lesions are refractory 
to treatment and the relapse rate is high (9). Most of the 
patients in our series (82.3%) underwent conventional 
surgery. Brouns et al. (22) likewise indicated surgery in 
most of their patients. Although there is no evidence that 
any concrete management strategy is truly able to pre-
vent the possible future development of oral squamous 
cell carcinoma (23), it seems safer to treat all lesions 
independently of the type of OL involved (7). The deci-
sion not to provide treatment should not be regarded as 
an option, due to ethical reasons (23). In turn, patients 
should be subjected to follow-up in order to identify any 
possible changes (21).
Most of the lesions in our series cured or showed no 
changes after treatment. Nevertheless, 8.3% of the le-
sions exhibited malignant transformation to oral squa-
mous cell carcinoma. Gándara-Vila et al. (24) reported 
a very similar percentage (8.2%) after an average of 
5.58 years of follow-up among their patients with OL. 
Einhorn and Wersall (25) studied 782 patients with a 
mean duration of follow-up of 11.7 years, and recorded 
a 3.93% malignization rate. Pindborg et al. (26) obtained 
very similar results (3.7%), while Roed-Petersen (27) re-
corded comparatively lower figures (2.7%).
Six percent of the 670 patients studied by Banoczy (28) 
showed malignant transformation – this being in line 
with the results of Warnakulasuriya et al. (6.9%) (29) 
(Table 4).
No fully reliable individual predictor of malignant trans-
formation has been established to date (7,10). In our 
series, non-homogeneous lesions were associated to a 
significant increase in malignization risk. This is con-
sistent with the findings of Gándara-Vila et al. (24), who 
reported a 5-fold greater risk of malignant transforma-
tion in the case of non-homogeneous lesions versus ho-
mogeneous lesions.
Brouns and van der Waal (22) did not find lesion loca-
tion to be an indicator of malignization risk. However, in 
our series, tongue lesions were seen to be significantly 
associated to malignization, in line with the observations 
of other authors (1,5,19,29).




Einhorn and Wersall (1967) Sweden 782 3.93%
Pindborg et al. (1968) Denmark 248 3.7%
Roed-Petersen (1971) Denmark 331 2.7%
Banoczy (1977) Hungary 670 6%
Warnakulasuriya et al. (2011) England 1357 6.9%
Gándara-Vila et al. (2018) Spain 85 8.2%
Present study (2020) Spain 412 8.3%
Table 4: Malignant transformation of oral leukoplakia lesions according to different studies.
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The presence and severity of epithelial dysplasia is one 
of the most important predictors of malignant trans-
formation in OL (1,29,30,). In coincidence with most 
other investigators, we found the presence and grade of 
dysplasia to significantly increase the risk of malignant 
transformation.
Thus, on the basis of the results obtained in our study, it 
can be concluded that the malignization risk factors are 
non-smoker status, a non-homogeneous clinical presen-
tation of the lesions, tongue lesions, and the presence 
and severity of epithelial dysplasia.
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